Age
Sleep Heart Health Study (SHHS) Visit Number vs Maximum duration of central apnea in REM sleep in non-supine position: Central apneas with >= 5% oxygen desaturation threshold used and with or without arousal from type II polysomnography
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Visit 1 | 251 | 21.8 | ± 10.1 | 18.0 | 10.0 | 67.0 | 5,553 | 5,804 |
| Interim Follow-up Visit | - | - | - | - | - | - | - | - |
| Visit 2 | 165 | 19.3 | ± 9.3 | 17.0 | 10.0 | 75.0 | 3,915 | 4,080 |
| CVD Outcomes | - | - | - | - | - | - | - | - |
Age at Sleep Heart Health Study Visit One (SHHS1) vs Maximum duration of central apnea in REM sleep in non-supine position: Central apneas with >= 5% oxygen desaturation threshold used and with or without arousal from type II polysomnography
Visit 1
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 251 | 21.8 | ± 10.1 | 18.0 | 10.0 | 67.0 | 5,553 | 5,804 |
| 35-44 years | 11 | 15.5 | ± 4.3 | 15.0 | 11.0 | 24.0 | 331 | 342 |
| 45-54 years | 57 | 20.9 | ± 11.0 | 17.0 | 10.0 | 67.0 | 960 | 1,017 |
| 55-64 years | 86 | 21.5 | ± 8.8 | 19.0 | 10.0 | 48.0 | 1,683 | 1,769 |
| 65-74 years | 61 | 20.5 | ± 7.6 | 18.0 | 10.0 | 44.0 | 1,556 | 1,617 |
| 75-84 years | 34 | 28.5 | ± 13.2 | 26.0 | 12.0 | 66.0 | 921 | 955 |
| 85 years or older | 2 | 23.5 | ± 16.3 | 23.5 | 12.0 | 35.0 | 102 | 104 |
Gender of the participant vs Maximum duration of central apnea in REM sleep in non-supine position: Central apneas with >= 5% oxygen desaturation threshold used and with or without arousal from type II polysomnography
Visit 1
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 251 | 21.8 | ± 10.1 | 18.0 | 10.0 | 67.0 | 5,553 | 5,804 |
| Male | 145 | 23.4 | ± 11.1 | 21.0 | 10.0 | 67.0 | 2,620 | 2,765 |
| Female | 106 | 19.7 | ± 7.9 | 17.5 | 10.0 | 48.0 | 2,933 | 3,039 |
Gender of the participant vs Maximum duration of central apnea in REM sleep in non-supine position: Central apneas with >= 5% oxygen desaturation threshold used and with or without arousal from type II polysomnography
Visit 2
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 165 | 19.3 | ± 9.3 | 17.0 | 10.0 | 75.0 | 3,915 | 4,080 |
| Male | 88 | 19.4 | ± 9.8 | 17.0 | 10.0 | 75.0 | 1,773 | 1,861 |
| Female | 77 | 19.2 | ± 8.8 | 17.0 | 10.0 | 52.0 | 2,142 | 2,219 |
Race of the participant vs Maximum duration of central apnea in REM sleep in non-supine position: Central apneas with >= 5% oxygen desaturation threshold used and with or without arousal from type II polysomnography
Visit 1
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 251 | 21.8 | ± 10.1 | 18.0 | 10.0 | 67.0 | 5,553 | 5,804 |
| White | 216 | 22.2 | ± 10.2 | 19.0 | 10.0 | 67.0 | 4,691 | 4,907 |
| Black | 23 | 20.8 | ± 8.8 | 19.0 | 11.0 | 49.0 | 492 | 515 |
| Other | 12 | 17.1 | ± 8.2 | 14.5 | 10.0 | 39.0 | 370 | 382 |
Race of the participant vs Maximum duration of central apnea in REM sleep in non-supine position: Central apneas with >= 5% oxygen desaturation threshold used and with or without arousal from type II polysomnography
Visit 2
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 165 | 19.3 | ± 9.3 | 17.0 | 10.0 | 75.0 | 3,915 | 4,080 |
| White | 148 | 18.7 | ± 8.2 | 17.0 | 10.0 | 57.0 | 3,439 | 3,587 |
| Black | 7 | 24.7 | ± 11.6 | 22.0 | 13.0 | 46.0 | 249 | 256 |
| Other | 10 | 24.5 | ± 18.5 | 19.5 | 12.0 | 75.0 | 227 | 237 |